Search - tctmd.com

Displaying 61 - 80 of 423

Sort: Relevancy | Date

News Daily News

Better Results With Newer Generation DES in Complex CAD Pave the Way for CABG Comparisons

March 15, 2016

News Daily News

新的双模式成像是否更易发现易损斑块？

March 14, 2016

News Daily News

¿Está una Técnica Doble de Imágenes está Más Cerca de Descubrir las Placas Vulnerables?

March 14, 2016

News Daily News

Does New Dual-Modality Imaging Come Closer to Uncovering Vulnerable Plaques?

March 14, 2016

News Conference News CRT 2016

Will the MitraClip and Other Gadgets Make Headway in Functional MR?

February 25, 2016

News Industry News

Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia

February 22, 2016

News Daily News

Análisis del Estudio Mesa: Las Imágenes Ateroscleróticas ‘Negativas’ Minimizan el Riesgo de ECV a los 10 Años

Michael O'Riordan

January 28, 2016

News Daily News

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

Michael O'Riordan

January 28, 2016

News Daily News

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

December 14, 2015

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

December 14, 2015

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Daily News

ILUMIEN II Raises Questions as to What OCT Offers Over IVUS

November 16, 2015

News Industry News

New Long-term Data Published in The Lancet Further Demonstrates Superiority of the CardioMEMS HF System over Standard of Care

November 08, 2015

News Conference News AHA 2015

Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain

November 08, 2015

News Daily News

Early Invasive Approach After Cardiac Arrest Gains Support

October 28, 2015

IN.PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions - Two-Year Outcomes

Presentation TCT 2015

IN.PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions - Two-Year Outcomes

Presenter: Cindy L. Grines, John R. Laird Jr

October 14, 2015

LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent Versus Bare Metal Stents in Patients With Coronary Artery Disease at High Risk for Bleeding

Presentation TCT 2015

LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent Versus Bare Metal Stents in Patients With Coronary Artery Disease at High Risk for Bleeding

Presenter: Cindy L. Grines, Philip M. Urban

October 14, 2015

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

Presentation TCT 2015

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

Presenter: Cindy L. Grines, Upendra Kaul

October 14, 2015

PANDA III: A Prospective Randomized Trial of Two Sirolimus-Eluting Bioresorbable-Polymer-Based Metallic Stents With Varying Elution and Absorption Kinetics

Presentation TCT 2015

PANDA III: A Prospective Randomized Trial of Two Sirolimus-Eluting Bioresorbable-Polymer-Based Metallic Stents With Varying Elution and Absorption Kinetics

Presenter: Cindy L. Grines, Bo Xu

October 14, 2015

ISAR-DESIRE 4: A Prospective Randomized Trial of Plaque Modification With a Scoring Balloon During Drug-Coated Balloon Treatment of Coronary In-Stent Restenosis

Presentation TCT 2015

ISAR-DESIRE 4: A Prospective Randomized Trial of Plaque Modification With a Scoring Balloon During Drug-Coated Balloon Treatment of Coronary In-Stent Restenosis

Presenter: Cindy L. Grines, Robert A. Byrne

October 14, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.